Intrinsiqs

Is Vir Biotechnology, Inc. overvalued?

Vir Biotechnology, Inc. (VIR) — key valuation metrics and fundamentals.

No verdict
Price
$9.09
Fair value
Current P/E
Normal P/E
Market cap
$1.53B
Dividend yield
0.0%
Return on equity
-30.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares VIR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.